NCT06116279View on ClinicalTrials.gov

First-in-human Experience Using Novel Ultraflexible Low-impedance Electrode Arrays: an IDEAL Stage 1 Study

NANot yet recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

February 1, 2025

Study Completion Date

August 1, 2025

Conditions
EpilepsyFocal Cortical Dysplasia
Interventions
DEVICE

Insertion of electrode during planned neurosurgery for epilepsy

A novel, 300 micrometer, ultraflexible, low-impedance electrode proposes to cause minimal parenchymal (brain tissue) damage, and provide multiple contacts at multiple depths to allow unit-level recordings for a period of 15 minutes.

Trial Locations (1)

WC1N 3JH

Great Ormond Street Hospital, London

All Listed Sponsors
lead

Great Ormond Street Hospital for Children NHS Foundation Trust

OTHER

NCT06116279 - First-in-human Experience Using Novel Ultraflexible Low-impedance Electrode Arrays: an IDEAL Stage 1 Study | Biotech Hunter | Biotech Hunter